Coherus Oncology Inc (CHRS)

Equity Ratio

31.82%

Quarterly · Period ending:

CHRS logo

CHRS Equity Ratio

Latest reported31.82%
CHRS Quarterly Equity Ratio (-89.32% → 31.82%)
High-resolution chart · PNG

CHRS equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Equity Ratio — Quarterly
Period endingEquity Ratio
31.8219%
29.5551%
23.6174%
16.9934%
27.2666%
-49.444%
-29.427%
-17.4204%
-12.4631%
-10.7189%
-30.7217%
-22.885%
-37.2162%
-48.8306%
-28.5783%
-17.6315%
-4.1445%
2.1172%
14.3856%
17.6292%
21.1239%
18.4149%
33.3838%
31.8179%
28.2017%
33.711%
25.7293%
17.1124%
-1.6573%
-20.6942%
-38.7978%
8.7614%
33.5463%
-1.3965%
18.7779%
29.614%
18.6588%
34.3638%
10.8435%
17.0891%
-24.2504%
-29.1757%
-3.2625%
19.7912%
38.6157%
24.9104%
35.6568%
7.2255%
12.0221%
-86.9021%
-89.3249%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.